Contract number: [***] COLLABORATIVE RESEARCH AND LICENSE AGREEMENT between Boehringer Ingelheim International GmbH Binger Strasse 173, 55216 Ingelheim am Rhein, Germany (“BOEHRINGER”) VAT-ID-No.: DE [***] and Dicerna Pharmaceuticals Inc. Cambridge,...Collaborative Research and License Agreement • March 8th, 2018 • Dicerna Pharmaceuticals Inc • Pharmaceutical preparations
WHEREAS BOEHRINGER is a research-based pharmaceutical company and is interested in a research program related to DICERNA’s proprietary GalXC technology which enables precise silencing of disease-driving genes in the liver, specifically targeting the hepatocyte.
